Physician profile
Lori Hansen
NPI 1235130030
$9,650.47
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,698 · 2020: $6,355 · 2021: $190 · 2022: $154 · 2023: $108 · 2024: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $8,774.73 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $295.99 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $228.80 | 2021-2024 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $122.58 | 2021-2024 | Tezspire |
| Sunovion Pharmaceuticals INC. | $107.23 | 2019 | |
| Amgen INC. | $52.47 | 2023-2024 | Tezspire |
| United Therapeutics Corporation | $23.12 | 2021 | |
| Insmed, INC. | $16.24 | 2020 | |
| Novartis Pharmaceuticals Corporation | $16.13 | 2024 | |
| Merck Sharp & Dohme LLC | $13.18 | 2023 | Verquvo, Belsomra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.